Drug Company ‘Shenanigans’ to Block Generics Come Under Federal Scrutiny

Drug Company ‘Shenanigans’ to Block Generics Come Under Federal Scrutiny-nytimes: Trump administration officials, seeking ways to lower drug costs, are targeting pharmaceutical companies that refuse to provide samples of their products to generic drug companies, making it impossible to create inexpensive generic copies of a brand-name medicine.